Details for New Drug Application (NDA): 208383
✉ Email this page to a colleague
The generic ingredient in BEVYXXA is betrixaban. Additional details are available on the betrixaban profile page.
Summary for 208383
Tradename: | BEVYXXA |
Applicant: | Portola Pharms Inc |
Ingredient: | betrixaban |
Patents: | 5 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 208383
Generic Entry Date for 208383*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 40MG | ||||
Approval Date: | Jun 23, 2017 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 8, 2026 | Product Flag? | Substance Flag? | Y | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 29, 2031 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | INHIBITING COAGULATION | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 8, 2028 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) |
Expired US Patents for NDA 208383
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription